238 related articles for article (PubMed ID: 17786070)
1. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States.
Patel BV; Remigio-Baker RA; Mehta D; Thiebaud P; Frech-Tamas F; Preblick R
J Clin Hypertens (Greenwich); 2007 Sep; 9(9):692-700. PubMed ID: 17786070
[TBL] [Abstract][Full Text] [Related]
2. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
Yokoyama K; Yang W; Preblick R; Frech-Tamas F
J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
[TBL] [Abstract][Full Text] [Related]
3. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
Mazzaglia G; Mantovani LG; Sturkenboom MC; Filippi A; Trifirò G; Cricelli C; Brignoli O; Caputi AP
J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
[TBL] [Abstract][Full Text] [Related]
4. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
5. A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice.
Veronesi M; Cicero AF; Prandin MG; Dormi A; Cosentino E; Strocchi E; Borghi C
Vasc Health Risk Manag; 2007; 3(6):999-1005. PubMed ID: 18200818
[TBL] [Abstract][Full Text] [Related]
6. [Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance].
Laux G; Szecsenyi J; Miksch A; Grün B; Gutscher A; Grün B; Rosemann T; Kühlein T
Med Klin (Munich); 2009 Feb; 104(2):108-13. PubMed ID: 19242661
[TBL] [Abstract][Full Text] [Related]
7. Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands.
Li X; Bijlsma MJ; Bos JHJ; Schuiling-Veninga CCM; Hak E
BMJ Open; 2023 Aug; 13(8):e068721. PubMed ID: 37558444
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
9. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.
Ah YM; Lee JY; Choi YJ; Kim B; Choi KH; Kong J; Oh JM; Shin WG; Lee HY
J Korean Med Sci; 2015 Dec; 30(12):1800-6. PubMed ID: 26713055
[TBL] [Abstract][Full Text] [Related]
10. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
[TBL] [Abstract][Full Text] [Related]
11. Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data.
Lachaine J; Petrella RJ; Merikle E; Ali F
Can J Cardiol; 2008 Apr; 24(4):269-73. PubMed ID: 18401466
[TBL] [Abstract][Full Text] [Related]
12. Changes in the phamacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics.
Siegel D; Lopez J; Meier J; Cunningham F
Am J Hypertens; 2001 Sep; 14(9 Pt 1):957-62. PubMed ID: 11587164
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
[TBL] [Abstract][Full Text] [Related]
14. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive persistence and drug class.
Marentette MA; Gerth WC; Billings DK; Zarnke KB
Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
[TBL] [Abstract][Full Text] [Related]
16. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
Marott SC; Nielsen SF; Benn M; Nordestgaard BG
Eur Heart J; 2014 May; 35(18):1205-14. PubMed ID: 24347316
[TBL] [Abstract][Full Text] [Related]
18. Costs of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary care.
Schäfer HH; Scheunert U
Swiss Med Wkly; 2013; 143():w13854. PubMed ID: 24163048
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review.
Park C; Wang G; Durthaler JM; Fang J
Am J Prev Med; 2017 Dec; 53(6S2):S131-S142. PubMed ID: 29153114
[TBL] [Abstract][Full Text] [Related]
20. Relation of the first hypertension-associated event with medication, compliance and persistence in naïve hypertensive patients after initiating monotherapy.
Mathes J; Kostev K; Gabriel A; Pirk O; Schmieder RE
Int J Clin Pharmacol Ther; 2010 Mar; 48(3):173-83. PubMed ID: 20197011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
